Chr. Hansen still sees probiotic potential despite ‘insufficient’ trial data
Chr. Hansen is still positive about probiotics – including in Europe – despite disappointing results in another two clinical trials, according to Chr. Hansen’s chief financial officer (CFO) Klaus Pedersen.